No Data
No Data
Express News | The top 50 companies in the A-share market cap management have been revealed, with 80% of the stocks receiving intensive "bullish" ratings from institutions.
Winner Medical (300888): The Consumer Business continues to grow rapidly, while the Medical Business remains stable.
The company's revenue in 2024 increased by 9.7% year-on-year to 8.98 billion yuan, with the Consumer business growing by 17% to 4.99 billion, and the Medical business increasing by 1% to 3.91 billion yuan. Revenue in Q1 2025 grew by 36% year-on-year.
Winner Medical (300888): The synergy of medical & Consumer development. Bullish on the brand's momentum continuing to rise.
Event: On April 29, 2025, Winner Medical released the 2024 annual report and the 2025 first quarter report: In 2024, the company achieved revenue of 8.978 billion yuan/year-on-year +9.69%, achieving a net income of 6.
Winner Medical (300888): In Q1, revenue from sanitary napkins increased by 74% year-on-year, driven by the dual engines of healthcare and Consumer growth.
The 2024 performance meets market expectations, and the 1Q25 performance exceeds our expectations. The company announced the 2024 and 1Q25 performance, with 2024 revenue increasing by 9.7% to 8.98 billion yuan, excluding infection protection products.
Winner Medical (300888): The Q1 performance is impressive, with accelerated income growth.
The company released its annual report and first quarter report: In 2024, the company achieved revenue of 8.98 billion yuan, +9.7% year-on-year, and net profit attributable to the parent company of 0.7 billion yuan, +19.8% year-on-year. Revenue performance exceeded our previous expectations (8.72 billion yuan).
Express News | Beauty care Concept stocks continue to rise, Marubi Biotechnology hit the daily limit in the afternoon.